Oncotelic Therapeutics, Inc. (OTLC) has 9 SEC Form 4 insider filings on record in the last 90 days. That includes 3 insider purchases totalling $23K. Most recent filing: July 23, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 23, 2026 filed July 10, 2026 | Fein Seymour Howard CRO/CMO | $0 | 250 | 0% | No | |
|
|
||||||
| July 21, 2026 filed July 10, 2026 | KING STEVEN W Director | $0 | 250 | 0% | No | |
|
|
||||||
| July 14, 2026 filed July 10, 2026 | Saund Saran CBO | $0 | 1,500 | 0% | No | |
|
|
||||||
| July 14, 2026 filed July 10, 2026 | Trieu Vuong CHAIRMAN AND CEO | $0 | 2,000 | 0% | No | |
|
|
||||||
| July 14, 2026 filed July 10, 2026 | Shah Amit B. CFO | $0 | 1,500 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free